Skip to main content
SpringerLink
Log in

Liver Transplantation: Perioperative Care and Update on Intraoperative Management

  • Transplantation Anesthesia (KG Belani, Section Editor)
  • Published:
Current Anesthesiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

We will present some relevant concepts on the preoperative evaluation of patients with end-stage liver disease and describe some new intraoperative management strategies for liver transplantation. This review is limited to three topics: cardiac issues, pulmonary issues, and coagulation issues.

Recent Findings

While dobutamine stress echocardiography and myocardial perfusion scintigraphy are the most common screening methods for coronary artery disease, computed tomography techniques are gaining popularity although their value is still unclear. Positive screening tests should be followed by coronary angiography and revascularization. Severe valvular heart disease has to be corrected before transplantation is attempted; percutaneous techniques virtually eliminate the risk of acute hepatic failure frequently associated with cardiopulmonary bypass in patients with severe liver disease. Extracorporeal membrane oxygenation is a viable treatment option when severe pulmonary and cardiac complications develop. Patients with severe hepatopulmonary syndrome can undergo successful liver transplantation, but portopulmonary hypertension remains challenging. Perioperative coagulation management will likely evolve with the availability of prothrombin complex concentrate and fibrinogen concentrate.

Summary

Rather than trying to provide a complete discussion, we emphasize new and interesting findings with significant clinical significance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS. Prediction of cardiac complications after liver transplantation. Transplantation. 2009;87(5):763–70.

    PubMed  Google Scholar 

  2. Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects. World J Gastroenterol. 2014;20(42):15499–517.

    PubMed  PubMed Central  Google Scholar 

  3. An J, Shim JH, Kim SO, Kim SO, Lee D, Kim KM, et al. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study. Circulation. 2014;130(16):1353–62.

    PubMed  Google Scholar 

  4. Di Carli MF, Blankstein R. Low yield of routine preoperative coronary computed tomography angiography in patients evaluated for liver transplantation. Circulation. 2014;130(16):1337–9.

    PubMed  Google Scholar 

  5. Friedrich-Rust M, Schoetzel F, Maier S, Seeger F, Rey J, Fichtlscherer S, et al. Severity of coronary artery disease is associated with non-alcoholic fatty liver disease: a single-blinded prospective mono-center study. PLoS One. 2017;12(10):e0186720.

    PubMed  PubMed Central  Google Scholar 

  6. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg. 1996;2(6):426–30.

    CAS  PubMed  Google Scholar 

  7. Wray C, Scovotti JC, Tobis J, Niemann CU, Planinsic R, Walia A, et al. Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study. Am J Transplant. 2013;13(1):184–91.

    CAS  PubMed  Google Scholar 

  8. Ehtisham J, Altieri M, Salamé E, Saloux E, Ollivier I, Hamon M. Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management. Liver Transpl. 2010;16(5):550–7.

    PubMed  Google Scholar 

  9. • Baker S, Chambers C, McQuillan P, Janicki P, Kadry Z, Bowen D, et al. Myocardial perfusion imaging is an effective screening test for coronary artery disease in liver transplant candidates. Clin Transplant. 2015;29(4):319–26. Myocardial perfusion imaging is an acceptable screening test for coronary artery disease in patients with liver disease.

    PubMed  Google Scholar 

  10. • Choi JM, Kong YG, Kang JW, Kim YK. Coronary computed tomography angiography in combination with coronary artery calcium scoring for the preoperative evaluation of liver transplant recipients. Biomed Res Int. 2017;2017:4081525. These CT-based techniques may have promise in the preoperative screening of liver transplant candidates for coronary artery disease.

    PubMed  PubMed Central  Google Scholar 

  11. Puchner SB, Lu MT, Mayrhofer T, Liu T, Pursnani A, Ghoshhajra BB, et al. High-risk coronary plaque at coronary CT angiography is associated with nonancoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. Radiology. 2015;274(3):693–701.

    PubMed  Google Scholar 

  12. Russo MW, Pierson J, Narang T, Montegudo A, Eskind L, Gulati S. Coronary artery stents and antiplatelet therapy in patients with cirrhosis. J Clin Gastroenterol. 2012;46(4):339–44.

    CAS  PubMed  Google Scholar 

  13. •• Raval Z, Harinstein ME, Flaherty JD. Role of cardiovascular intervention as a bridge to liver transplantation. World J Gastroenterol. 2014;20(31):10651–7. Most cardiology interventions in patients with end-stage liver disease are presented and discussed.

    PubMed  PubMed Central  Google Scholar 

  14. Gopaldas RR, Chu D, Cornwell LD, Dao TK, LeMaire SA, Coselli JS, et al. Cirrhosis as a moderator of outcomes in coronary artery bypass grafting and off-pump coronary artery bypass operations: a 12-year population-based study. Ann Thorac Surg. 2013;96(4):1310–5.

    PubMed  Google Scholar 

  15. Axelrod D, Koffron AL, DeWolf A, Baker A, Fryer J, Baker T, et al. Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting. Liver Transpl. 2004;10(11):1386–90.

    PubMed  Google Scholar 

  16. •• Markin NW, Sharma A, Grant W, Shillcutt SK. The safety of transesophageal echocardiography in patients undergoing orthotopic liver transplantation. J Cardiothor Vasc Anesth. 2015;29(3):588–93. This study confirms that intraoperative transesophageal echocardiography has a low complication rate.

    Google Scholar 

  17. •• Lee M, Weinberg L, Pearce B, Scurrah N, Story DA, Pillai P, et al. Agreement between radial and femoral arterial blood pressure measurements during liver transplantation. Crit Care Resusc. 2015;17(2):101–7. During liver transplantation femoral arterial pressures better reflect central aortic pressure and therefore perfusion pressure of the essential organs as compared to radial arterial pressures.

    PubMed  Google Scholar 

  18. •• Skaro AI, Gallon LG, Lyuksemburg V, Jay CL, Zhao L, Ladner DP, et al. The impact of coronary artery disease on outcomes after liver transplantation. J Cardiovasc Med. 2016;17(12):875–85. Appropriately treated coronary artery disease is not a contraindication to liver transplantation.

    Google Scholar 

  19. Møller S, Henriksen JH. Cirrhotic cardiomyopathy (review). J Hepatol. 2010;53(1):179–90.

    PubMed  Google Scholar 

  20. Zardi EM, Zardi DM, Chin D, Sonnino C, Dobrina A, Abbate A. Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase. (review) J Cardiol. 2016;67(2):125–30.

    PubMed  Google Scholar 

  21. Saner FH, Neumann T, Canbay A, Treckmann JW, Hartmann M, Goerlinger K, et al. High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients. Transpl Int. 2011;24(5):425–32.

    CAS  PubMed  Google Scholar 

  22. • Tandon M, Karna ST, Pandey CK, Chaturvedi R. Diagnostic and Therapeutic challenge of heart failure after liver transplant: case series. World J Hepatol. 2017;9(33):1253–60. Cirrhotic cardiomyopathy remains difficult to diagnose and treat.

    PubMed  PubMed Central  Google Scholar 

  23. Cywinski JB, Argalious M, Marks TN, Parker BM. Dynamic left ventricular outflow tract obstruction in an orthotopic liver transplant recipient. Liver Transpl. 2005;11(6):692–5.

    PubMed  Google Scholar 

  24. Kia L, Shah SJ, Wang E, Sharma D, Selvaraj S, Medina C, et al. Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation. Am J Transplant. 2013;13(9):2395–401.

    CAS  PubMed  Google Scholar 

  25. Bushyhead D, Kirkpatrick JN, Goldberg D. Pretransplant echocardiographic parameters as markers of posttransplant outcomes in liver transplant recipients. Liver Transpl. 2016;22(3):316–23.

    PubMed  Google Scholar 

  26. • Araujo L, Dombrovskiy V, Kamran W, Lemaire A, Chiricolo A, Lee LY, et al. The effect of preoperative liver dysfunction on cardiac surgery outcomes. J Cardiothorac Surg. 2017;12(1):73. Cardiac surgery in patients with significant liver disease is associated with a high morbidity and mortality rate.

    PubMed  PubMed Central  Google Scholar 

  27. Filsoufi F, Salzberg SP, Rahmanian PB, Schiano TD, Elsiesy H, Squire A, et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl. 2007;13(7):990–5.

    PubMed  Google Scholar 

  28. Harrison JD, Selzman CH, Thiesset HF, Box T, Hutson WR, Lu JK, et al. Minimally invasive aortic valve replacement with orthotopic liver transplantation: report of a case. Surg Today. 2014;44(3):546–9.

    PubMed  Google Scholar 

  29. Coverstone E, Korenblat K, Crippin JS, Chapman WC, Kates AM, Zajarias A. Aortic balloon valvuloplasty prior to orthotopic liver transplantation: a novel approach to aortic stenosis and end-stage liver disease. Case Rep Cardiol. 2014;2014:325136.

    PubMed  PubMed Central  Google Scholar 

  30. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.

    CAS  PubMed  Google Scholar 

  31. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tazcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477–84.

    PubMed  Google Scholar 

  32. Cabasa AS, Eleid MF, Suri RM. Transcatheter aortic valve replacement for native aortic valve regurgitation as a bridge to liver transplantation. Catheter Cardiovasc Interv. 2016;88(4):665–70.

    PubMed  Google Scholar 

  33. Maddur H, Bourdillon PD, Liangpunsakul S, Tector AJ, Fridell JA, Ghabril M, et al. Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation. Liver Transpl. 2014;20(6):664–72.

    PubMed  Google Scholar 

  34. Moreno R, Delcán JL, García E, Villacastín J, Ortega A, Pérez E. Emergent mitral percutaneous valvuloplasty before emergent liver transplantation. Catheter Cardiovasc Diagn. 1997;41(2):229–30.

    CAS  Google Scholar 

  35. Puri R, Abdul-Jawad Altisent O, del Trigo M, Campelo-Parada F, Regueiro A, Barbosa Ribeiro H, et al. Transcatheter mitral valve implantation for inoperable severely calcified native mitral valve disease: a systematic review. Catheter Cardiovasc Interv. 2016;87(3):540–8.

    PubMed  Google Scholar 

  36. Velazquez EJ, Samad Z, Al-Khalidi HR, Sangli C, Grayburn PA, Massaro JM, et al. The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J. 2015;170(5):1050–9.

    PubMed  Google Scholar 

  37. Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, et al. OPTN/SRTR 2013 annual data report: liver. Am J Transplant. 2015;15:1–28.

    PubMed  Google Scholar 

  38. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2014;64(21):e1–76.

    PubMed  Google Scholar 

  39. • Bargehr J, Trejo-Gutierrez JF, Patel T, Rosser B, Aranda-Michel J, Yataco ML, et al. Preexisting atrial fibrillation and cardiac complications after liver transplantation. Liver Transpl. 2015;21(3):314–20. Despite a higher perioperative morbidity, atrial fibrillation did not affect overall graft and patient survival.

    PubMed  Google Scholar 

  40. • Vannucci A, Rathor R, Vachharajani N, Chapman W, Kangrga I. Atrial fibrillation in patients undergoing liver transplantation - a single-center experience. Transplant Proc. 2014;46(5):1432–7. But these authors report a higher postoperative mortality.

    CAS  PubMed  Google Scholar 

  41. • Xia VW, Worapot A, Huang S, Dhillon A, Gudzenko V, Backon A, et al. Postoperative atrial fibrillation in liver transplantation. Am J Transplant. 2015;15(3):687–94. And these authors also found an increased mortality and graft failure with atrial fibrillation.

    CAS  PubMed  Google Scholar 

  42. Fleming GM, Cornell TT, Welling TH, Magee JC, Annich GM. Hepatopulmonary syndrome: use of extracorporeal life support for life-threatening hypoxia following liver transplantation. Liver Transpl. 2008;14(7):966–70.

    PubMed  PubMed Central  Google Scholar 

  43. Monsel A, Mal H, Brisson H, Luo R, Eyraud D, Vézinet C, et al. Extracorporeal membrane oxygenation as a bridge to liver transplantation for acute respiratory distress syndrome-induced life-threatening hypoxaemia aggravated by hepatopulmonary syndrome. Crit Care. 2011;15(5):R234.

    PubMed  PubMed Central  Google Scholar 

  44. Park YH, Hwang S, Park HW, Lee HJ, Namgoong JM, Yoon SY, et al. Effect of pulmonary support using extracorporeal membrane oxygenation for adult liver transplant recipients with respiratory failure. Transplant Proc. 2012;44(3):757–61.

    PubMed  Google Scholar 

  45. Auzinger G, Willars C, Loveridge R, Best T, Vercueil A, Prachalias A, et al. Extracorporeal membrane oxygenation for refractory hypoxemia after liver transplantation in severe hepatopulmonary syndrome: a solution with pitfalls. Liver Transpl. 2014;20(9):1141–4.

    PubMed  Google Scholar 

  46. Aufhauser DD Jr, Rose T, Levine M, Barnett R, Ochroch EA, Aukburg S, et al. Cardiac arrest associated with reperfusion of the liver during transplantation: incidence and proposal for a management algorithm. Clin Transpl. 2013;27(2):185–92.

    Google Scholar 

  47. Bittner HB, Binner C, Lehmann S, Kuntze T, Rastan A, Mohr FW. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Eur J Cardiothorac Surg. 2007;31(3):462–7.

    PubMed  Google Scholar 

  48. Tejani M, Yi SY, Eudailey KW, George I, Guarrera JV, Wagener G. Extracorporeal membrane oxygenation as a rescue device for postreperfusion cardiac arrest during liver transplantation. Liver Transpl. 2015;21(3):410–4.

    PubMed  Google Scholar 

  49. Pasha AK, Elder MD, Khurram D, Snyder BA, Movahed MR. Successful management of acute massive pulmonary embolism using Angiovac suction catheter technique in a hemodynamically unstable patient. Cardiovasc Revasc Med. 2014;15(4):240–3.

    PubMed  Google Scholar 

  50. Szocik J, Rudich S, Csete C. ECMO resuscitation after massive pulmonary embolism during liver transplantation. Anesthesiology. 2002;97(3):763–4.

    PubMed  Google Scholar 

  51. Dell'Amore A, Botta L, Gallieri S, Arpesella G. Extracorporeal membrane oxygenator assistance as “bridge” to combined heart and liver transplantation. Transplant Proc. 2006;38(9):3004–5.

    CAS  PubMed  Google Scholar 

  52. Ceulemans LJ, Vos R, Neyrinck A, Pirenne J, Warnecke G, Van Raemdonck D. Liver-first versus lung-first: a new dilemma in combined organ transplantation. Transpl Int. 2018;31(2):230–1.

    PubMed  Google Scholar 

  53. Scheiermann P, Czerner S, Kaspar M, Schramm R, Winter H, Wimmer CD, et al. Combined lung and liver transplantation with extracorporeal membrane oxygenation instead of cardiopulmonary bypass. J Cardiothor Vasc Anesth. 2016;30(2):437–42.

    Google Scholar 

  54. • Ravikumar R, Jassem W, Mergental H, Heaton N, Mirza D, Perera MP, et al. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am J Transplant. 2016;16(6):1779–87. Normothermic machine preservation appears to be both safe and feasible.

    CAS  PubMed  Google Scholar 

  55. Schön MR, Kollmar O, Wolf S, Schrem H, Matthes M, Akkoc N, et al. Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg. 2001;233(1):114–23.

    PubMed  PubMed Central  Google Scholar 

  56. Foley DP, Fernandez LA, Leverson G, Anderson M, Mezrich J, Sollinger HW, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011;253(4):817–25.

    PubMed  PubMed Central  Google Scholar 

  57. Shapey IM, Muiesan P. Regional perfusion by extracorporeal membrane oxygenation of abdominal organs from donors after circulatory death: a systematic review. Liver Transpl. 2013;19(12):1292–303.

    PubMed  Google Scholar 

  58. Pascasio J, Grilo I, López-Pardo F, Ortega-Ruiz F, Tirado JL, Sousa JM, et al. Prevalence and severity of hepatopulmonary syndrome and its influence on survival in cirrhotic patients evaluated for liver transplantation. Am J Transplant. 2014;14(6):1391–9.

    CAS  PubMed  Google Scholar 

  59. •• Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, et al. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation. 2016;100(7):1440–52. A thorough discussion of both pulmonary complications of liver disease.

    PubMed  Google Scholar 

  60. Saigal S, Choudhary N, Saraf N, Kotecha H, Kakodkar R, Mohanka R, et al. Excellent outcome of living donor liver transplantation in patients with hepatopulmonary syndrome: a single Centre experience. Clin Transpl. 2013;27(4):530–4.

    Google Scholar 

  61. Gupta S, Castel H, Rao RV, Picard M, Lilly L, Faughnan ME, et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant. 2010;10(2):354–63.

    CAS  PubMed  Google Scholar 

  62. Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome—a liver-induced lung vascular disorder. N Engl J Med. 2008;358(22):2378–87.

    CAS  PubMed  Google Scholar 

  63. • Nayyar D, Man HSJ, Granton J, Lilly LB, Gupta S. Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome. Am J Transplant. 2015;15(4):903–13. Excellent presentation of all treatment options for hepatopulmonary syndrome.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Chihara Y, Egawa H, Tsuboi T, Oga T, Handa T, Yamomoto K, et al. Immediate noninvasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantation. Liver Transpl. 2011;17(2):144–8.

    PubMed  Google Scholar 

  65. Udoji TN, Berkowitz DM, Bechara RI, Hanish S, Subramanian RM. The use of transtracheal oxygen therapy in the management of severe hepatopulmonary syndrome after liver transplantation. Transplant Proc. 2013;45(9):3316–9.

    CAS  PubMed  Google Scholar 

  66. Schiffer E, Majno P, Mentha G, Giostra E, Burri H, Klopfenstein CE, et al. Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients. Am J Transplant. 2006;6(6):1430–7.

    CAS  PubMed  Google Scholar 

  67. Ramsay M. Portopulmonary hypertension and right heart failure in patients with cirrhosis. Curr Opin Anaesthesiol. 2010;23(2):145–50.

    PubMed  Google Scholar 

  68. •• Bozbas SS, Bozbas H. Pulmonary hypertension in liver transplant candidates. World J Gastroenterol. 2016;22(6):2024–9. A review article that discusses all aspects of portopulmonary hypertension.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Afifi S, Shayan S, Al-Qamari A. Pulmonary hypertension and right ventricular function: interdependence in pathophysiology and management. Int Anesthesiol Clin. 2009;47(1):97–120.

    PubMed  Google Scholar 

  70. Paulsen AW, Whitten CW, Ramsay MAE, Klintmalm GB. Considerations for anesthetic management during veno-venous bypass in adult hepatic transplantation. Anesth Analg. 1989;68(4):489–96.

    CAS  PubMed  Google Scholar 

  71. Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant. 2008;8(11):2445–53.

    CAS  PubMed  Google Scholar 

  72. Burger-Klepp U, Karatosic R, Thum M, Schwarzer R, Fuhrmann V, Hetz H, et al. Transesophageal echocardiography during orthotopic liver transplantation in patients with esophagogastric varices. Transplantation. 2012;94(2):192–6.

    PubMed  Google Scholar 

  73. Lu SY, Matsusaki T, Abuelkasem E, Sturdevant ML, Humar A, Hilmi IA, et al. Complications related to invasive hemodynamic monitors during adult liver transplantation. Clin Transpl. 2013;27(6):823–8.

    Google Scholar 

  74. •• Pai SL, Aniskevich SIII, Feinglass NG, Ladlie BL, Crawford CC, Peiris P, et al. Complications related to intraoperative transesophageal echocardiography in liver transplantation. SpringerPlus. 2015;4(4):480. TEE is remarkably safe in patients undergoing liver transplantation.

    PubMed  PubMed Central  Google Scholar 

  75. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41(3):553–8.

    CAS  PubMed  Google Scholar 

  76. Lisman T, Bakhtiari K, Pereboom ITA, Hendriks HGD, Meijers JCM, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol. 2010;52(3):355–61.

    CAS  PubMed  Google Scholar 

  77. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116(6):878–85.

    CAS  PubMed  Google Scholar 

  78. Warnaar N, Lisman T, Porte RJ. The two tales of coagulation in liver transplantation. Curr Opin Organ Transplant. 2008;13(3):298–303.

    PubMed  Google Scholar 

  79. • Abuelkasem E, Hasan S, Mazzeffi MA, Planinsic RM, Sakai T, Tanaka KA. Reduced requirement for prothrombin complex concentrate for the restoration of thrombin generation in plasma from liver transplant recipients. Anesth Analg. 2017;125(2):609–15. This work provides further insight into the rebalanced hemostasis in patients with severe liver disease.

    CAS  PubMed  Google Scholar 

  80. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147–56.

    CAS  PubMed  Google Scholar 

  81. Senzolo M, Rodriguez-Castro KI, Rossetto V, Radu C, Gavasso S, Carraro P, et al. Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis. J Thromb Haemost. 2012;10(9):1823–9.

    CAS  PubMed  Google Scholar 

  82. •• Lisman T, Porte RJ. Value of preoperative hemostasis testing in patients with liver disease for perioperative hemostatic management. Anesthesiology. 2017;126(2):338–44. Routine preoperative coagulation tests poorly predict transfusion requirements.

    PubMed  Google Scholar 

  83. Cywinski JB, Alster JM, Miller C, Vogt DP, Parker BM. Prediction of intraoperative transfusion requirements during orthotopic liver transplantation and the influence on postoperative patient survival. Anesth Analg. 2014;118(2):428–37.

    PubMed  Google Scholar 

  84. Findlay JY, Rettke SR. Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables. J Clin Anesth. 2000;12(4):319–23.

    CAS  PubMed  Google Scholar 

  85. Massicotte L, Sassine MP, Lenis S, Roy A. Transfusion predictors in liver transplant. Anesth Analg. 2004;98(5):1245–51.

    PubMed  Google Scholar 

  86. Massicotte L, Thibeault L, Roy A. Classical notions of coagulation revisited in relation with blood losses, transfusion rate for 700 consecutive liver transplantations. Semin Thromb Hemost. 2015;41(5):538–46.

    PubMed  Google Scholar 

  87. de Boer MT, Molenaar IQ, Hendriks HG, Slooff MJ, Porte RJ. Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg. 2005;22(4):265–75.

    PubMed  Google Scholar 

  88. Porte RJ, Caldwell SH. The role of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11(8):872–4.

    PubMed  Google Scholar 

  89. Tripodi A, Primignani M, Chantarangkul V, Lemma L, Jovani M, Rebulla P, et al. Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion. Liver Int. 2013;33(3):362–7.

    PubMed  Google Scholar 

  90. Tripodi A, Chantarangkul V, Primignani M, Clerici M, Dell’era A, Aghemo A, et al. Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma. Intern Emerg Med. 2012;7(2):139–44.

    PubMed  Google Scholar 

  91. Haas T, Fries D, Tanaka KA, Asmis L, Curry NS, Schöchl H. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth. 2015;114(2):217–24.

    CAS  PubMed  Google Scholar 

  92. Pustavoitau A, Lesley M, Ariyo P, Latif A, Villamayor AJ, Franks SM, et al. Predictive modeling of massive transfusion requirements during liver transplantation and its potential to reduce utilization of blood bank resources. Anesth Analg. 2017;124(5):1644–52.

    PubMed  Google Scholar 

  93. Pereboom ITA, de Boer MT, Haagsma EB, Hendriks HGD, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg. 2009;108(4):1083–91.

    PubMed  Google Scholar 

  94. de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ, et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg. 2008;106(1):32–44.

    PubMed  Google Scholar 

  95. •• Chin JL, Hisamuddin SH, O’Sullivan A, Chan G, PA MC. Thrombocytopenia, Platelet transfusion, and outcome following liver transplantation. Clin Appl Thromb Hemost. 2016;22(4):351–60. Transfusion of blood products has real consequences.

    PubMed  Google Scholar 

  96. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119(7):1757–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  97. Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc. 2010;42(7):2590–3.

    PubMed  Google Scholar 

  98. Alamo JM, León A, Mellado P, Bernal C, Marín LM, Cepeda C, et al. Is “intra-operating room” thromboelastometry useful in liver transplantation? A case-control study in 303 patients. Transplant Proc. 2013;45(10):3637–9.

    PubMed  Google Scholar 

  99. Roullet S, Freyburger G, Cruc M, Quinart A, Stecken L, Audy M, et al. Management of bleeding and transfusion during liver transplantation before and after the introduction of a rotational thromboelastometry-based algorithm. Liver Transpl. 2015;21(2):169–79.

    PubMed  Google Scholar 

  100. Fayed N, Mourad W, Yassen K, Görlinger K. Preoperative thromboelastometry as a predictor of transfusion requirements during adult living donor liver transplantation. Transfus Med Hemother. 2015;42(2):99–108.

    PubMed  PubMed Central  Google Scholar 

  101. Debernardi Venon W, Ponzo P, Sacco M, Mengozzi G, Raso S, Valpreda A, et al. Usefulness of thromboelastometry in predicting the risk of bleeding in cirrhotics who undergo invasive procedures. Eur J Gastroenterol Hepatol. 2015;27(11):1313–9.

    PubMed  Google Scholar 

  102. De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology. 2016;63:566–73.

    PubMed  Google Scholar 

  103. Abuelkasem E, Mazzeffi MA, Lu SY, Planinsic RM, Sakai T, Tanaka KA. Ex-vivo evaluation of 4 different viscoelastic assays for detecting moderate to severe coagulopathy during liver transplantation. Liver Transpl. 2016;22(4):468–75.

    PubMed  Google Scholar 

  104. Abuelkasem E, Lu S, Tanaka K, Planinsic R, Sakai T. Comparison between thrombelastography and thromboelastometry in hyperfibrinolysis detection during adult liver transplantation. Br J Anaesth. 2016;116(4):507–12.

    CAS  PubMed  Google Scholar 

  105. Müller MCA, Straat M, Meijers JCM, Klinkspoor JH, de Jonge E, Arbous MS, et al. Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy. J Thromb Haemost. 2015;13(6):989–97.

    PubMed  Google Scholar 

  106. • Marshall AL, Levine M, Howell ML, Chang Y, Riklin E, Parry BA, et al. Dose-associated pulmonary complication rates after fresh frozen plasma administration for warfarin reversal. J Thromb Haemost. 2016;14(2):324–30. Administration of large volumes of fresh frozen plasma can result in volume overload.

    CAS  PubMed  Google Scholar 

  107. Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet. 2015;385(9982):2077–87.

    CAS  PubMed  PubMed Central  Google Scholar 

  108. Refaai MA, Goldstein JN, Lee ML, Durn BL, Milling TJ Jr, Sarode R. Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal. Transfusion. 2015;55(11):2722–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  109. Lorenz R, Kienast J, Otto U, Egger K, Kiehl M, Schreiter D, et al. Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol. 2003;15(1):15–20.

    CAS  PubMed  Google Scholar 

  110. • Kirchner C, Dirkmann D, Treckmann JW, Paul A, Hartmann M, Saner FH, et al. Coagulation management with factor concentrates in liver transplantation: a single-center experience. Transfusion. 2014;54(10):2760–8. Fibrinogen concentrate and prothrombin complex concentrate do not appear to be associated with thrombosis and ischemic events.

    PubMed  Google Scholar 

  111. Arshad F, Ickx B, van Beem RT, Polak W, Grüne F, Nevens F, et al. Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg. 2013;13:22.

    CAS  PubMed  PubMed Central  Google Scholar 

  112. Karri JV, Cardenas JC, Johansson PI, Matijevic N, Cotton BA, Wade CE, et al. In vitro efficacy of RiaSTAP after rapid reconstitution. J Surg Res. 2014;190(2):655–61.

    CAS  PubMed  Google Scholar 

  113. • Sabate A, Gutierrez R, Beltran J, Mellado P, Blasi A, Acosta F, et al. Impact of preemptive fibrinogen concentrate on transfusion requirements in liver transplantation: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Transplant. 2016;16(8):2421–9. Pre-emptive administration of fibrinogen concentrate did not influence transfusion requirements.

    CAS  PubMed  Google Scholar 

  114. Groeneveld DJ, Adelmeijer J, Hugenholtz GCG, Ariëns RAS, Porte RJ, Lisman T. Ex vivo addition of fibrinogen concentrate improves the fibrin network structure in plasma samples taken during liver transplantation. J Thromb Haemost. 2015;13(12):2192–201.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, 251 East Huron Street, F5-704, Chicago, IL, 60611, USA

    Joshua Herborn, Choy Lewis & Andre De Wolf

Authors
  1. Joshua Herborn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Choy Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andre De Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andre De Wolf.

Ethics declarations

Conflict of Interest

Joshua Herborn has received speaker’s honoraria from Edwards Lifesciences.

Choy Lewis declares that she has no conflict of interest.

Andre De Wolf declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Transplantation Anesthesia

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herborn, J., Lewis, C. & De Wolf, A. Liver Transplantation: Perioperative Care and Update on Intraoperative Management. Curr Anesthesiol Rep 8, 186–196 (2018). https://doi.org/10.1007/s40140-018-0270-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40140-018-0270-9

Keywords

Search

Navigation